Wen‐Lian Wu

974 total citations
38 papers, 747 citations indexed

About

Wen‐Lian Wu is a scholar working on Organic Chemistry, Molecular Biology and Physiology. According to data from OpenAlex, Wen‐Lian Wu has authored 38 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Organic Chemistry, 14 papers in Molecular Biology and 9 papers in Physiology. Recurrent topics in Wen‐Lian Wu's work include Asymmetric Synthesis and Catalysis (5 papers), Receptor Mechanisms and Signaling (5 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Wen‐Lian Wu is often cited by papers focused on Asymmetric Synthesis and Catalysis (5 papers), Receptor Mechanisms and Signaling (5 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Wen‐Lian Wu collaborates with scholars based in United States, China and Italy. Wen‐Lian Wu's co-authors include Yulin Wu, David J. Hart, Alan P. Kozikowski, Yulin Wu, Duane A. Burnett, Bo Su, Zhang‐Jie Shi, William J. Greenlee, Bin Ye and Yang Gao and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Cancer Research.

In The Last Decade

Wen‐Lian Wu

36 papers receiving 695 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen‐Lian Wu United States 15 479 243 101 50 50 38 747
Robert J. Mathvink United States 13 506 1.1× 191 0.8× 66 0.7× 21 0.4× 31 0.6× 19 737
Karl R. Gibson United Kingdom 15 460 1.0× 255 1.0× 72 0.7× 32 0.6× 29 0.6× 27 796
Minoru Moriya Japan 18 564 1.2× 281 1.2× 88 0.9× 44 0.9× 48 1.0× 40 1.1k
Giampaolo Primofiore Italy 21 833 1.7× 546 2.2× 124 1.2× 47 0.9× 45 0.9× 83 1.2k
Li‐Qiang Sun United States 16 413 0.9× 320 1.3× 51 0.5× 25 0.5× 23 0.5× 40 873
Hoh‐Gyu Hahn South Korea 15 423 0.9× 187 0.8× 33 0.3× 41 0.8× 29 0.6× 60 737
Kevin G. Liu United States 16 399 0.8× 281 1.2× 87 0.9× 30 0.6× 25 0.5× 21 603
Bernard Hulin United States 15 339 0.7× 307 1.3× 39 0.4× 101 2.0× 46 0.9× 23 645
Eric Goffin Belgium 18 330 0.7× 383 1.6× 180 1.8× 38 0.8× 24 0.5× 40 751
Barry C. Ross United Kingdom 16 372 0.8× 505 2.1× 100 1.0× 23 0.5× 48 1.0× 38 905

Countries citing papers authored by Wen‐Lian Wu

Since Specialization
Citations

This map shows the geographic impact of Wen‐Lian Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Lian Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Lian Wu more than expected).

Fields of papers citing papers by Wen‐Lian Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Lian Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Lian Wu. The network helps show where Wen‐Lian Wu may publish in the future.

Co-authorship network of co-authors of Wen‐Lian Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Lian Wu. A scholar is included among the top collaborators of Wen‐Lian Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Lian Wu. Wen‐Lian Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Tianqi, Simiao Liu, Fang Wang, et al.. (2025). Insufficient telomeric DNA damage response promotes chromosomal instability in aged oocytes. Science Bulletin. 70(20). 3382–3396.
2.
Zhang, Ling, Tianqi Cao, Simiao Liu, et al.. (2024). NSUN2 is critical for mouse oocyte meiosis and early embryonic development. Reproduction. 168(6). 1 indexed citations
3.
Wang, Fang, Tianqi Cao, Simiao Liu, et al.. (2024). Age‐associated accumulation of RAB9 disrupts oocyte meiosis. Aging Cell. 24(4). e14449–e14449.
4.
Wu, Wen‐Lian, Jinsong Hao, Hongwu Wang, et al.. (2021). Design and discovery of C2-fluoroalkyl iminothiazine dioxides as BACE inhibitors. Bioorganic & Medicinal Chemistry Letters. 56. 128463–128463. 3 indexed citations
5.
Pissarnitski, Dmitri, Zhiqiang Zhao, David Cole, et al.. (2016). Scaffold-hopping from xanthines to tricyclic guanines: A case study of dipeptidyl peptidase 4 (DPP4) inhibitors. Bioorganic & Medicinal Chemistry. 24(21). 5534–5545. 13 indexed citations
6.
Wu, Wen‐Lian, Duane A. Burnett, John W. Clader, et al.. (2016). Design and synthesis of water soluble β-aminosulfone analogues of SCH 900229 as γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(23). 5836–5841. 2 indexed citations
7.
Wu, Wen‐Lian, Jinsong Hao, Martin S. Domalski, et al.. (2016). Discovery of Novel Tricyclic Heterocycles as Potent and Selective DPP-4 Inhibitors for the Treatment of Type 2 Diabetes. ACS Medicinal Chemistry Letters. 7(5). 498–501. 38 indexed citations
8.
Gilbert, Eric J., Andrew P. J. Brunskill, Jiaqiang Cai, et al.. (2016). A novel domino reaction for the preparation of substituted non-racemic β-proline derivatives. Tetrahedron. 72(40). 6011–6020. 1 indexed citations
9.
Zhao, Zhiqiang, Dmitri Pissarnitski, Hubert Josien, et al.. (2015). Discovery of a Novel, Potent Spirocyclic Series of γ-Secretase Inhibitors. Journal of Medicinal Chemistry. 58(22). 8806–8817. 19 indexed citations
10.
Burnett, Duane A., William J. Greenlee, Chad Knutson, et al.. (2012). Fused tricyclic mGluR1 antagonists for the treatment of neuropathic pain. Bioorganic & Medicinal Chemistry Letters. 22(4). 1575–1578. 20 indexed citations
11.
Tulshian, Deen, Julius J. Matasi, Qiang Li, et al.. (2012). Synthesis and SAR development of novel mGluR1 antagonists for the treatment of chronic pain. Bioorganic & Medicinal Chemistry Letters. 22(23). 7223–7226. 8 indexed citations
12.
Burnett, Duane A., Theodros Asberom, Wen‐Lian Wu, et al.. (2010). Tetracyclic sulfones as potent γ-secretase inhibitors: Synthesis and structure–activity relationship studies. Bioorganic & Medicinal Chemistry Letters. 20(12). 3645–3648. 6 indexed citations
13.
Wu, Wen‐Lian, Duane A. Burnett, Martin S. Domalski, et al.. (2007). Discovery of Orally Efficacious Tetracyclic Metabotropic Glutamate Receptor 1 (mGluR1) Antagonists for the Treatment of Chronic Pain. Journal of Medicinal Chemistry. 50(23). 5550–5553. 30 indexed citations
14.
Li, Qiang, Wen‐Lian Wu, Duane A. Burnett, et al.. (2006). Tetrahydroisoquinolines as MCH-R1 antagonists. Bioorganic & Medicinal Chemistry Letters. 16(18). 4917–4921. 6 indexed citations
15.
Wu, Wen‐Lian, Duane A. Burnett, Qiang Li, et al.. (2006). Synthesis and structure–activity relationships of piperidine-based melanin-concentrating hormone receptor 1 antagonists. Bioorganic & Medicinal Chemistry Letters. 16(14). 3668–3673. 4 indexed citations
16.
Wu, Wen‐Lian, Duane A. Burnett, Mary Ann Caplen, et al.. (2006). Design and synthesis of orally efficacious benzimidazoles as melanin-concentrating hormone receptor 1 antagonists. Bioorganic & Medicinal Chemistry Letters. 16(14). 3674–3678. 12 indexed citations
17.
Wu, Wen‐Lian, Mary Ann Caplen, Martin S. Domalski, et al.. (2002). Synthesis and structure–activity relationships of aminoalkylazetidines as ORL1 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 12(21). 3157–3160. 11 indexed citations
18.
Wu, Yonggang, et al.. (1996). Stereoselective synthesis of acyclic natural products containing chiral vicinal diol. Pure and Applied Chemistry. 68(3). 727–734. 9 indexed citations
19.
Hart, David J. & Wen‐Lian Wu. (1996). Observations regarding the first step of the Julia-Lythgoe olefin synthesis. Tetrahedron Letters. 37(30). 5283–5286. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026